PriceSensitive

Apiam Animal Health (ASX:AHX) secures viral vaccine lab funding

ASX News, Health Care
ASX:AHX      MCAP $62.59M
30 March 2022 18:33 (AEST)

Apiam Animal Health (AHX) has been awarded a $700,000 grant to build a new viral vaccine laboratory in Bendigo from the Victorian State Government’s Regional Jobs Fund.

The funding will enable the company to fast track development of the facility.

AHX said producing viral vaccines locally will fill a critical gap in Australia’s animal health market, with a strong potential for future exports.

It will fill a need within the domestic agricultural industry to battle a range of endemic and emerging viruses.

This includes Japanese Encephalitis, which is currently affecting the domestic pig segment.

It has started collaboration with potential vaccine research partner, La Trobe University, and is working to execute a formal collaboration agreement.

Managing Director Dr Chris Richards said there is significant market potential within this area.

“We look forward to being able to provide a greater range of animal health solutions to our customer base and working with our livestock industries and communities to deliver better protection for their livestock,” he said.

“We are also pleased to add approximately 40 jobs to our local Regional Victorian communities.”

Shares closed flat today at 85 cents each.

Related News